According to the latest report by IMARC Group, “Global Antacids Market Growth, Share, Size, Industry Trends, Opportunity and Forecast 2022-2027“, the global antacids market reached a value of US$ 6.35 Billion in 2021. Looking forward, IMARC Group expects the market to reach a value of US$ 8.27 Billion by 2027 exhibiting a CAGR of 4.20% during 2022-2027.
Antacids are over-the-counter (OTC) medicines that neutralize the acid in the stomach to cure heartburn and indigestion. They cure dyspepsia discomfort, inflammation, stomach upset, acid indigestion, and stomach ulcers. They consist of ingredients such as aluminium, hydroxide, calcium, magnesium, and bicarbonate. They are self-prescribed medicines that neutralize acids and inhibit pepsin.
Note: We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.
| Report Metric |
| Historical: 2016-2021 |
| Base Year: 2021 |
| Forecast Year: 2022-2027 |
Antacids Market Trends and Drivers:
One of the primary factors driving the market is the rising prevalence of gastroesophageal reflux diseases (GERD) amongst the masses. Additionally, they are consumed as chewable tablets in different flavors that provide the correct dosage amount, improve patient adherence and are easy to store.
Request Free Sample Report: https://www.imarcgroup.com/antacids-market/requestsample
Besides this, the sedentary lifestyles and the numerous product innovations, such as the introduction of raft-forming antacids that are strong and safe medications and offer efficacy and increased duration of action, are catalyzing the market growth. Other factors strengthening the market growth are the easy accessibility of these antacids through online and offline platforms, increasing prevalence of heartburn among the masses and expanding geriatric population that is susceptible to acidic complications.
Global Antacids Market 2022-2027 Analysis and Segmentation:
Competitive Landscape:
The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market.
Abbott Laboratories, AstraZeneca plc, Bayer AG, Boehringer Ingelheim International GmbH, Dr. Reddy’s Laboratories Ltd., GlaxoSmithKline plc, Johnson & Johnson, Pfizer Inc., Procter & Gamble Company, Reckitt Benckiser Group PLC, Sanofi S.A., Sun Pharmaceutical Industries Ltd. and Takeda Pharmaceutical Company Limited.
The report has segmented the market on the basis of region, drug class, formulation type and distribution channel.
Breakup by Drug Class:
- Proton Pump Inhibitors
- H2 Antagonist
- Acid Neutralizers
- Pro-Motility Agents
Breakup by Formulation Type:
- Tablet
- Liquid
- Powder
- Others
Breakup by Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Others
Breakup by Region:
- North America: (United States, Canada)
- Asia Pacific: (China, Japan, India, South Korea, Australia, Indonesia, Others)
- Europe: (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
- Latin America: (Brazil, Mexico, Others)
- Middle East and Africa
Ask Analyst for Customization and Explore Full Report with TOC & List of Figure: https://www.imarcgroup.com/request?type=report&id=5082&flag=C
If you want latest primary and secondary data (2022-2027) with Cost Module, Business Strategy, Distribution Channel, etc. Click request free sample report, published report will be delivered to you in PDF format via email within 24 to 48 hours of receiving full payment.
Key highlights of the report:
- Market Performance (2016-2021)
- Market Outlook (2022- 2027)
- Porter’s Five Forces Analysis
- Market Drivers and Success Factors
- SWOT Analysis
- Value Chain
- Comprehensive Mapping of the Competitive Landscape
If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.
Who we are:
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact Us:
IMARC Services Private Limited.
30 N Gould St Ste R
Sheridan, WY 82801 USA – Wyoming
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800
0
